Net selling: insiders sold $1.6M and bought $0 on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full results8 funds hold a position and insiders have been net selling.
Buys/Adds (1)
Qube Research
$14.8M
added
Sells/Trims (2)
Qube Research
$19.2M
trimmed
Marshall Wace
$22.9M
trimmed
Top-trader positions in BEAM could not be loaded.
Hyperliquid positioning - not every stock is covered
Last report
Aug 4, 2026
Period ending
Jun 30, 2026
Earnings per share
$1.00 expected
Revenue
Financial statements: Alpha Vantage
| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / income | Surprise |
|---|---|---|---|---|---|
| Jun 30, 2026 | Aug 4, 2026 | -$1.18 / $1.00Alpha Vantage | -$2.18 miss | $490.0K No estimate | Unavailable |
| Mar 31, 2026 | May 7, 2026 | -$0.91 / -$1.01Alpha Vantage | +9.90% beat | $31.7M No estimate | Unavailable |
| Dec 31, 2025 | Feb 24, 2026 | $2.33 / -$1.01Alpha Vantage | +$3.34 beat | $114.1M No estimate | Unavailable |
| Sep 30, 2025 | Nov 4, 2025 | -$1.10 / -$1.01Alpha Vantage | -8.91% miss | $9.7M No estimate | Unavailable |
| Jun 30, 2025 | Aug 5, 2025 | -$1.00 / -$1.09Alpha Vantage | +8.26% beat | $8.5M No estimate | Unavailable |
| Mar 31, 2025 | May 6, 2025 | -$1.24 / -$1.17Alpha Vantage | -5.98% miss | $7.5M No estimate | Unavailable |
| Dec 31, 2024 | Feb 25, 2025 | -$1.09 / -$1.22Alpha Vantage | +10.35% beat | $30.1M No estimate | Unavailable |
| Sep 30, 2024 | Nov 5, 2024 | -$1.17 / -$1.18Alpha Vantage | +0.85% in line | $14.3M No estimate | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue and income use company releases, SEC filings, Alpha Vantage or Yahoo Finance. Non-USD revenue carries its currency code. Comparisons require a paired release estimate.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $9.7M | $114.1M | $31.7M | $490.0K |
| Cost of what it sold | $109.8M | $5.7M | $11.1M | — |
| Gross profit | -$100.1M | $108.4M | $20.7M | $490.0K |
| What it spent | ||||
| Research and development | $109.8M | $99.3M | $104.5M | $95.1M |
| Sales and admin | $26.7M | $26.6M | $34.4M | $31.9M |
| Other operating costs | -$109.8M | — | -$11.1M | — |
| Total operating expenses | $26.7M | $125.9M | $127.9M | $127.0M |
| What was left | ||||
| Operating profit | -$126.8M | -$17.4M | -$107.2M | -$126.6M |
| Interest on debt | $10.9M | $10.6M | $9.9M | $7.5M |
| Profit before tax | -$112.7M | $244.3M | -$94.3M | -$122.7M |
| Net profit | -$112.7M | $244.3M | -$94.3M | -$122.7M |
| EBITDA | -$107.2M | $260.6M | -$88.7M | -$125.0M |
This stock is under pressure.
Trend
Under pressure
15 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace